Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
The majority of published preclinical research on BPC-157 for connective tissue applications used injectable administration
The peptide addresses connective tissue conditions (tendonitis and ligament ruptures) by accelerating structural repair at the cellular level
BPC-157 lacks FDA approval as a drug or dietary supplement ingredient approved for human administration
Sadly, we are not always sure about the quality of our food sources
To determine whether these effects were limited to -synuclein-induced neurodegeneration, we performed timecourse exposures in two other neurodegeneration models
US$ 28.06
![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
US$ 28.27
US$ 25.20
US$ 20.84
US$ 21.04
